{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:09:05Z","timestamp":1789690145587,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","award":["23OK1056"],"award-info":[{"award-number":["23OK1056"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011929","name":"Programa Operacional Tem\u00e1tico Factores de Competitividade","doi-asserted-by":"publisher","award":["NCT04745195"],"award-info":[{"award-number":["NCT04745195"]}],"id":[{"id":"10.13039\/501100011929","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004528","name":"Maastricht Universitair Medisch Centrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004528","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.modpat.2024.100690","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T20:09:46Z","timestamp":1734379786000},"page":"100690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Etiology and Outcomes of Kidney-Limited and Systemic Thrombotic Microangiopathy"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0854-2317","authenticated-orcid":false,"given":"Daan P.C.","family":"van Doorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachid","family":"Tobal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrurgia A.","family":"Abdul-Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"van Paassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd A.M.E.G.","family":"Timmermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.modpat.2024.100690_bib1","first-page":"3034","article-title":"The syndromes of thrombotic microangiopathy: a critical appraisal on complement dysregulation","volume":"10","author":"Timmermans","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"11","key":"10.1016\/j.modpat.2024.100690_bib2","doi-asserted-by":"crossref","first-page":"E426","DOI":"10.1002\/ajh.26705","article-title":"The prevalence and clinical outcomes of microangiopathic hemolytic anemia in patients with biopsy-proven renal thrombotic microangiopathy","volume":"97","author":"Bhutani","year":"2022","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.modpat.2024.100690_bib3","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.kint.2024.02.014","article-title":"Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies","volume":"105","author":"Maisons","year":"2024","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.modpat.2024.100690_bib4","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.ekir.2021.01.034","article-title":"Functional and genetic landscape of complement dysregulation along the spectrum of thrombotic microangiopathy and its potential implications on clinical outcomes","volume":"6","author":"Timmermans","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1016\/j.modpat.2024.100690_bib5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \"Kidney Disease: Improving Global Outcomes\" (KDIGO) Controversies Conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.modpat.2024.100690_bib6","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.2215\/CJN.14721219","article-title":"Major bleeding and risk of death after percutaneous native kidney biopsies: a French nationwide cohort study","volume":"15","author":"Halimi","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100690_bib7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ki.1987.179","article-title":"Epidemiology of idiopathic glomerular disease: a prospective study","volume":"32","author":"Tiebosch","year":"1987","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.modpat.2024.100690_bib8","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1523-1755.2004.00835.x","article-title":"Signs and symptoms of thin basement membrane nephropathy: a prospective regional study on primary glomerular disease-the Limburg Renal Registry","volume":"66","author":"van Paassen","year":"2004","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.modpat.2024.100690_bib9","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1681\/ASN.2018020184","article-title":"C5b9 formation on endothelial cells reflects complement defects among patients with renal thrombotic microangiopathy and severe hypertension","volume":"29","author":"Timmermans","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.modpat.2024.100690_bib10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.kint.2017.01.002","article-title":"A\u00a0proposal for standardized grading of chronic changes in native kidney biopsy specimens","volume":"91","author":"Sethi","year":"2017","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.modpat.2024.100690_bib11","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/ndt\/gfv288","article-title":"Complement in ANCA-associated glomerulonephritis","volume":"32","author":"Hilhorst","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.modpat.2024.100690_bib12","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1309\/AJCPXPD7ZQXNTIAL","article-title":"Effect of blood sampling, processing, and storage on the measurement of complement activation biomarkers","volume":"143","author":"Yang","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2024.100690_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.modpat.2024.100690_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.imbio.2013.06.004","article-title":"Standardisation of the factor H autoantibody assay","volume":"219","author":"Watson","year":"2014","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.modpat.2024.100690_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfad306","article-title":"The spectrum of thrombotic microangiopathy related to monoclonal gammopathy","volume":"17","author":"van Doorn","year":"2024","journal-title":"Clin Kidney J"},{"issue":"3","key":"10.1016\/j.modpat.2024.100690_bib16","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ekir.2023.01.002","article-title":"C3 glomerulopathy and thrombotic microangiopathy: a \"Hybrid\" phenotype","volume":"8","author":"Timmermans","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1016\/j.modpat.2024.100690_bib17","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.kint.2024.05.021","article-title":"An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working Group","volume":"106","author":"Nester","year":"2024","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.modpat.2024.100690_bib18","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1182\/blood.2020005171","article-title":"More about complement in the antiphospholipid syndrome","volume":"136","author":"Timmermans","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.modpat.2024.100690_bib19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.kint.2024.06.009","article-title":"Kidney-limited TMA is common in patients with complement dysregulation","volume":"106","author":"van Doorn","year":"2024","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.modpat.2024.100690_bib20","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.kint.2016.07.021","article-title":"Collapsing glomerulopathy is common in the setting of thrombotic microangiopathy of the native kidney","volume":"90","author":"Buob","year":"2016","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.modpat.2024.100690_bib21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00467-003-1385-9","article-title":"Clinico-pathological findings in diarrhoea-negative haemolytic uraemic syndrome","volume":"19","author":"Taylor","year":"2004","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100690_bib22","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/HYPERTENSIONAHA.119.13714","article-title":"Diagnostic and risk factors for complement defects in hypertensive emergency and thrombotic microangiopathy","volume":"75","author":"Timmermans","year":"2020","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.modpat.2024.100690_bib23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF01476776","article-title":"Endotheliotropic (hemolytic) nephroangiopathy and its various manifestation forms (thrombotic microangiopathy, primary malignant nephrosclerosis, hemolytic-uremic syndrome)","volume":"58","author":"Thoenes","year":"1980","journal-title":"Klin Wochenschr"},{"issue":"6","key":"10.1016\/j.modpat.2024.100690_bib24","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.kint.2016.12.009","article-title":"Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities","volume":"91","author":"Timmermans","year":"2017","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.modpat.2024.100690_bib25","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.3324\/haematol.2019.216903","article-title":"Impact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndrome","volume":"104","author":"El Karoui","year":"2019","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.modpat.2024.100690_bib26","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.kint.2019.05.014","article-title":"Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome","volume":"96","author":"Cavero","year":"2019","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.modpat.2024.100690_bib27","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.modpat.2024.100690_bib28","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.modpat.2024.100690_bib29","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.kint.2019.01.023","article-title":"Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors","volume":"95","author":"Le Clech","year":"2019","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.modpat.2024.100690_bib30","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2215\/CJN.0000000000000182","article-title":"Epidemiology, outcomes, and complement gene variants in secondary thrombotic microangiopathies","volume":"18","author":"Werion","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.modpat.2024.100690_bib31","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1681\/ASN.2017121260","article-title":"The prognostic value of histopathologic lesions in native kidney biopsy specimens: results from the Boston Kidney Biopsy Cohort Study","volume":"29","author":"Srivastava","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.modpat.2024.100690_bib32","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/j.1523-1755.2004.00922.x","article-title":"Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy","volume":"66","author":"Manno","year":"2004","journal-title":"Kidney Int"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395224002709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395224002709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T04:00:06Z","timestamp":1762315206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395224002709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0893395224002709"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2024.100690","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Etiology and Outcomes of Kidney-Limited and Systemic Thrombotic Microangiopathy","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2024.100690","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"100690"}}